Canopy Growth Stock Forecast, Price & News

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last year. There are currently 5 sell ratings, 10 hold ratings, 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Canopy Growth stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CGC, but not buy additional shares or sell existing shares.
View analyst ratings for Canopy Growth or view top-rated stocks.

Wall Street analysts have given Canopy Growth a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Canopy Growth wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Canopy Growth saw a decrease in short interest in February. As of February 12th, there was short interest totaling 11,950,000 shares, a decrease of 45.8% from the January 28th total of 22,040,000 shares. Based on an average daily volume of 7,050,000 shares, the short-interest ratio is presently 1.7 days. Approximately 5.2% of the company's stock are sold short.
View Canopy Growth's Short Interest.

Canopy Growth is scheduled to release its next quarterly earnings announcement on Friday, June 4th 2021.
View our earnings forecast for Canopy Growth.

Canopy Growth Co. (NASDAQ:CGC) released its quarterly earnings results on Monday, February, 8th. The company reported ($2.43) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.21) by $2.22. The company had revenue of $153 million for the quarter, compared to analysts' expectations of $149.94 million. Canopy Growth had a negative net margin of 312.84% and a negative trailing twelve-month return on equity of 13.11%. The firm's revenue was up 23.4% on a year-over-year basis. During the same quarter last year, the firm earned ($0.35) EPS.
View Canopy Growth's earnings history.

Canopy Growth's stock was trading at $13.35 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CGC shares have increased by 149.0% and is now trading at $33.24.
View which stocks have been most impacted by COVID-19.

20 brokerages have issued 1-year price targets for Canopy Growth's stock. Their forecasts range from $21.10 to $64.00. On average, they expect Canopy Growth's share price to reach $38.57 in the next year. This suggests a possible upside of 16.0% from the stock's current price.
View analysts' price targets for Canopy Growth or view top-rated stocks among Wall Street analysts.

Some companies that are related to Canopy Growth include (ALIOF) (ALIOF), STADA Arzneimittel Aktiengesellschaft (STDAF), Aphria (APHA), Tilray (TLRY), Cronos Group (CRON), USANA Health Sciences (USNA), Aurora Cannabis (ACB), Sundial Growers (SNDL), HEXO (HEXO), ChromaDex (CDXC), Canopy Rivers (RIV), Charlie's (CHUC), MediWound (MDWD), Natural Alternatives International (NAII) and Nutra Pharma (NPHC).
View all of CGC's competitors.

Canopy Growth trades on the NASDAQ under the ticker symbol "CGC."

Canopy Growth's stock is owned by many different institutional and retail investors. Top institutional investors include ETF Managers Group LLC (0.79%), Morgan Stanley (0.43%), The Manufacturers Life Insurance Company (0.29%), Swiss National Bank (0.24%), Voloridge Investment Management LLC (0.23%) and Toronto Dominion Bank (0.19%). Company insiders that own Canopy Growth stock include Phillip Stephen Shaer, Rade Nikola Kovacevic and Tomas Iv Shipley.
View institutional ownership trends for Canopy Growth.

CGC stock was sold by a variety of institutional investors in the last quarter, including CIBC World Markets Inc., Toronto Dominion Bank, Sumitomo Mitsui Trust Holdings Inc., Swiss National Bank, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp, Dimensional Fund Advisors LP, Public Sector Pension Investment Board, and Bank of New York Mellon Corp. Company insiders that have sold Canopy Growth company stock in the last year include Phillip Stephen Shaer, Rade Nikola Kovacevic, and Tomas Iv Shipley.
View insider buying and selling activity for Canopy Growth or view top insider-selling stocks.

CGC stock was purchased by a variety of institutional investors in the last quarter, including Voloridge Investment Management LLC, ETF Managers Group LLC, Maple Rock Capital Partners Inc., Credit Suisse AG, LPL Financial LLC, CIBC Asset Management Inc, Renaissance Technologies LLC, and State of Wisconsin Investment Board.
View insider buying and selling activity for Canopy Growth or or view top insider-buying stocks.

Shares of CGC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CGC stock can currently be purchased for approximately $33.24.

Canopy Growth has a market capitalization of $12.49 billion and generates $297.34 million in revenue each year. The company earns $-993,370,000.00 in net income (profit) each year or $1.32 on an earnings per share basis.

Canopy Growth employs 4,434 workers across the globe.

The official website for Canopy Growth is www.canopygrowth.com.

Canopy Growth is headquartered at 1 HERSHEY DRIVE, SMITH FALLS A6, K7A0A8.

Canopy Growth's mailing address is 1 HERSHEY DRIVE, SMITH FALLS A6, K7A0A8. The company can be reached via phone at 855 558 9333 or via email at [email protected]